As of my last update in October 2023, "Necrosis inhibitor 3" with the CAS number 2258670-86-7 is a chemical compound that has been studied for its potential therapeutic applications, particularly in the context of preventing cell death associated with necrosis. While specific characteristics such as molecular structure, solubility, and stability may vary, compounds in this category typically exhibit properties that allow them to interact with cellular pathways involved in apoptosis and necrosis. These substances may function by modulating signaling pathways, inhibiting specific enzymes, or altering the cellular environment to promote cell survival. Research into necrosis inhibitors often focuses on their efficacy, safety, and mechanism of action, particularly in relation to diseases characterized by excessive cell death, such as neurodegenerative disorders or ischemic injuries. However, detailed information regarding its pharmacokinetics, toxicity, and clinical applications may still be under investigation, and further studies are necessary to fully understand its potential benefits and limitations in medical use.

Necrosis inhibitor 3

2258670-86-7: As of my last update in October 2023, "Necrosis inhibitor 3" with the CAS number 2258670-86-7 is a chemical compound that has been studied for its potential therapeutic applications, particularly in the context of preventing cell death associated with necrosis. While specific characteristics such as molecular structure, solubility, and stability may vary, compounds in this category typically exhibit properties that allow them to interact with cellular pathways involved in apoptosis and necrosis. These substances may function by modulating signaling pathways, inhibiting specific enzymes, or altering the cellular environment to promote cell survival. Research into necrosis inhibitors often focuses on their efficacy, safety, and mechanism of action, particularly in relation to diseases characterized by excessive cell death, such as neurodegenerative disorders or ischemic injuries. However, detailed information regarding its pharmacokinetics, toxicity, and clinical applications may still be under investigation, and further studies are necessary to fully understand its potential benefits and limitations in medical use.

<p>Necrosis Inhibitor 3 (compound B3) effectively inhibits necrosis, demonstrating an IC50 of 0.29 nM in HT29 cells [1].</p>

CAS 2258670-86-7

Necrosis inhibitor 3

Necrosis inhibitor 3

Ref: TM-T86990